SCHEMBL7285389

SCHEMBL7285389

Cn1c2c(c3cccc(F)c31)C(=O)CCC2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 1/20 0.38
BTK Q06187 1/20 0.38
BUB1 O43683 1/20 0.38
KDM4E B2RXH2 2/20 0.36
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
HTR2B P41595 1/20 0.36
CSNK2A1 P68400 2/20 0.35
CSNK2A2 P19784 1/20 0.35
CSNK2B P67870 1/20 0.35
ABCG2 Q9UNQ0 1/20 0.35
DYRK1A Q13627 1/20 0.35
ALDH1A1 P00352 1/20 0.35
PKM P14618 1/20 0.35
PTGS1 P23219 2/20 0.34
PTGS2 P35354 2/20 0.34
PARP1 P09874 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
HDAC1 Q13547 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7294032 0.81 BCHE (0.49)
SCHEMBL17895742 0.79 KDM4E (0.38) JAK2BTKBUB1KDM4ECSNK2A1
SCHEMBL7285293 0.79 KDM4E (0.41) JAK2BTKKDM4EHTR2AHTR2C
SCHEMBL7285283 0.79 KDM4E (0.41) JAK2BTKKDM4EHTR2AHTR2C
SCHEMBL7285339 0.78 BRD4 (0.42) JAK2BTKPARP1CREBBPBRD4
SCHEMBL6921111 0.76 CSNK2A2 (0.53) CSNK2A1CSNK2A2CSNK2BABCG2PTGS1
SCHEMBL23537658 0.75 BUB1 (0.43) BUB1KDM4EHTR2AHTR2CCSNK2A1
SCHEMBL1146660 0.75 HTR2A (0.51) BUB1KDM4EHTR2AHTR2CALDH1A1
SCHEMBL30223533 0.75 HTR2A (0.51) BUB1KDM4EHTR2AHTR2CALDH1A1
SCHEMBL29824768 0.75 BUB1 (0.43) BUB1KDM4EHTR2AHTR2CCSNK2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0353983-B1 Lactam derivatives GLAXO GROUP LTD (GB) 1996-05-29 EP disclosed
US-5202343-A Treating anxiety, psychological disorders GLAXO GROUP LIMITED (GB) 1993-04-13 US disclosed
US-5183820-A Useful for treatment of nausea, vomiting, irritable bowel syndrome and dyspepsia GLAXO GROUP LIMITED (GB) 1993-02-02 US disclosed
EP-0353983-A2 Lactam derivatives GLAXO GROUP LIMITED (GB) 1990-02-07 EP disclosed
US-4859662-A Tetrahydro-imidazolylmethylcarbazolones and analogs thereof for treating 5-HT function disturbances GLAXO GROUP LIMITED (GB) 1989-08-22 US disclosed